Bipolar Disorder in Teenagers: Signs, Diagnosis, and Treatment
Author: Ukrainian Psychological Hub · Published: October 9, 2026 · Editorial Policy
Bipolar disorder can begin during adolescence, when sleep, relationships, identity, school demands, and emotional regulation are already changing rapidly. The clinical distinction is the presence of recognizable episodes in which mood changes together with energy, activity, sleep, thinking, and behavior, representing a significant departure from the teenager’s usual functioning. Persistent irritability, difficult family interactions, ordinary excitement, or a teenager having an unusually good or bad day do not establish bipolar disorder. A careful assessment considers what changed, when it began, how long it lasted, what happened between episodes, and how the change affected safety and daily life. National Institute of Mental Health (NIMH) ISBD pediatric bipolar disorder task force
A teenager may first seek help because of depression, academic decline, conflict at home, anxiety, risk-taking, or problems sleeping. A manic or hypomanic period may be less obvious in the story than the depression that followed it. A specialist therefore asks about the course over time rather than assuming that the problem visible today is the whole condition. This article explains signs, differential diagnosis, assessment, treatment, safety, and family and school support. For the general diagnostic framework, see Bipolar Disorder: Symptoms, Types, Diagnosis, and Treatment.
For additional clinical context, see Bipolar Disorder in Children: Symptoms and Diagnostic Challenges and Bipolar Disorder in Older Adults: Diagnosis, Medications, and Care.
What is bipolar disorder in teenagers?
Bipolar and related disorders are clinical conditions involving episodes of abnormally elevated, expansive, or irritable mood accompanied by altered energy or activity. Depressive episodes can occur as well. Bipolar I disorder is defined by at least one manic episode. Bipolar II disorder requires at least one hypomanic episode and one major depressive episode, without a history of mania. Cyclothymic disorder involves longer-lasting patterns of symptoms that fall below full episode thresholds; other specified and unspecified bipolar presentations require their own clinical consideration. These distinctions apply to young people, although age and development influence how symptoms are noticed and interpreted. CANMAT/ISBD 2023 evidence update ISBD pediatric bipolar disorder task force
The word “mood” by itself captures too little. Mania involves a syndrome: a cluster of changes in activation, sleep, speech, attention, judgment, and behavior occurring together. The diagnostic question is whether there was a distinct interval with a departure from baseline and clinically meaningful consequences. Adolescents can experience genuine periods of wellness between episodes, although residual symptoms and difficulties in functioning may persist. Some first episodes emerge in adolescence while a definitive longitudinal diagnosis becomes clearer over follow-up. Carlson, differential diagnosis review National Institute of Mental Health (NIMH)
Bipolar I, bipolar II, and shorter or subthreshold presentations
Mania ordinarily persists for at least seven days, or for any duration when hospitalization becomes necessary because of the severity of the episode. Marked impairment, hospitalization, or psychotic symptoms distinguish mania from hypomania. Hypomania lasts at least four consecutive days under the conventional DSM framework, represents an unmistakable change in functioning, and does not itself cause the marked impairment or psychosis associated with mania. A major depressive episode conventionally lasts at least two weeks. A shorter spell or an uncertain history deserves assessment; it should not be made to fit a diagnostic label by rounding up its duration. CANMAT/ISBD 2023 evidence update ISBD pediatric bipolar disorder task force
Bipolar II can entail prolonged or severe depression and major functional harm, even though the elevated episodes are hypomanic rather than manic. Families sometimes describe hypomania as a period when the teenager seemed productive, social, unusually confident, or simply “back to normal.” The crucial comparison is with the young person’s usual personality, sleep need, decisions, and behavior. See Bipolar I Disorder: Symptoms, Diagnosis, and Treatment, Bipolar II Disorder: Symptoms, Diagnosis, and Treatment, and Hypomania: Symptoms, Duration, and Clinical Significance for the distinct episode definitions.
A young person with a few days of unusual activation or a strong family history may require follow-up and monitoring, not an instant diagnosis of bipolar I or II. Clinicians may document provisional or other specified presentations when the evidence fits and keep revising the working formulation as longitudinal information accumulates. The ISBD task force emphasizes both diagnostic rigor and the importance of studying subthreshold presentations without treating risk as certainty. ISBD pediatric bipolar disorder task force
Early signs of bipolar disorder in teenagers
The most informative early signs appear together, during a definable change from baseline. A teenager who is normally quiet may suddenly become unusually talkative, sleep only a few hours without feeling tired, launch multiple unrealistic projects, and take conspicuous risks for several days. Another may show very pronounced elevated or irritable mood, abrupt increases in activity, rapid speech, grandiose ideas, and impaired judgment. The same behaviors can mean something different when they have been present steadily for years or occur only during an acute stressor. NIMH: Signs for teens and young adults National Institute of Mental Health (NIMH)
Signs of mania or hypomania
Potential signs include a noticeably elevated, expansive, or persistently irritable mood; markedly increased energy or goal-directed activity; much less need for sleep without ordinary next-day fatigue; unusually rapid or pressured speech; racing thoughts or rapidly shifting ideas; increased distractibility; exaggerated confidence or grandiosity; agitation; and impulsive decisions involving money, driving, sex, substances, or online behavior. Severe episodes may include delusions, hallucinations, or loss of sound judgment and require urgent assessment. Any one item alone is insufficient for diagnosis. National Institute of Mental Health (NIMH) NIMH: Signs for teens and young adults
A reduced need for sleep is particularly useful to describe precisely. A teenager who stays awake gaming and then feels exhausted is experiencing sleep deprivation. During mania, someone may sleep very little yet report feeling unusually energized and rested. The observation does not prove mania, but it helps the clinician distinguish a mood episode from a disrupted sleep schedule. Persistent sleep loss can also worsen symptoms regardless of the eventual diagnosis. ISBD pediatric bipolar disorder task force
Irritability is common in adolescence and appears in numerous clinical conditions. An irritable manic episode is evaluated by the entire concurrent syndrome, its episodic onset and offset, and its contrast with baseline. Chronic anger, recurrent outbursts, and difficulty tolerating frustration call for their own differential assessment. They do not independently establish bipolar disorder. NICE takes an especially cautious diagnostic approach in younger patients and stresses specialist longitudinal observation; its specific youth criteria are more restrictive than some DSM-based clinical formulations. NICE guideline CG185, section 1.11 Carlson, differential diagnosis review
Signs of bipolar depression
A depressive episode may involve pervasive low mood or loss of pleasure, withdrawal from friends and interests, low energy, changes in appetite or weight, sleeping too much or too little, diminished concentration, guilt, hopelessness, slowed behavior or agitation, and thoughts of death or suicide. Teenagers may describe numbness or overwhelming irritability more readily than sadness. Falling grades, missed classes, changes in hygiene, and isolation can be consequences, although none is specific to bipolar depression. National Institute of Mental Health (NIMH) NIMH: Signs for teens and young adults
Depression can be the first recognized episode. Asking about any previous periods of increased activation, sleep reduction, and behavioral change is therefore essential before concluding that depressive symptoms represent unipolar major depression. A family history of bipolar disorder increases clinical concern but cannot convert a depressive episode into a bipolar diagnosis without the required episode history. NICE guideline CG185, section 1.11 CANMAT/ISBD 2023 evidence update
Mixed features and rapidly changing symptoms
Mixed features refer to depressive and manic or hypomanic symptoms appearing within the same episode, rather than simply alternating between happy and sad moods. An adolescent may have severe depressive thoughts together with marked agitation, racing thoughts, increased energy, or reduced need for sleep. These clinical combinations require close attention to suicide risk, judgment, and treatment planning. Rapid cycling is a course specifier based on four or more qualifying mood episodes within twelve months; it does not refer to mood changing several times within one ordinary day. CANMAT/ISBD 2023 evidence update Bipolar Disorder With Mixed Features
How is bipolar disorder different from normal teenage mood changes?
Ordinary developmental fluctuations respond to events, sleep, social interactions, frustration, and changing responsibilities. Their intensity varies, but they generally lack the sustained cluster of altered mood and activation that defines a manic or hypomanic episode. Clinically important mood episodes persist beyond momentary reactions, represent an observable shift from typical functioning, and involve consequences for learning, relationships, self-care, or safety. Some teens hide symptoms at home while peers or teachers notice unusual activity, or vice versa, making observations from several settings valuable. Carlson, differential diagnosis review ISBD pediatric bipolar disorder task force
The distinction is not whether emotions seem intense to an adult. A reaction may be understandable while still deserving care, and an apparently cheerful period may represent a serious episode if accompanied by a greatly reduced sleep need and impaired judgment. Duration, pattern, context, associated symptoms, and functional change carry more diagnostic weight than a parent’s impression of how “dramatic” the mood looked. ISBD pediatric bipolar disorder task force
How bipolar disorder is diagnosed in adolescents
There is no blood test, MRI, genetic assay, or online questionnaire that independently confirms bipolar disorder. Diagnosis rests on clinical evaluation of episode patterns, severity, duration, impairment, alternative explanations, medication or substance effects, and functioning over time. A clinician may order laboratory studies or other tests to evaluate medical causes or establish safe medication monitoring, but those investigations are not diagnostic biomarkers for bipolar disorder. National Institute of Mental Health (NIMH) NICE guideline CG185, section 1.11
NICE recommends that diagnosis in children and young people be made by professionals experienced in youth bipolar disorder after intensive prospective longitudinal monitoring and collaboration with parents or caregivers. In the United States, child and adolescent psychiatrists also use structured clinical interviews, collateral information, and longitudinal follow-up. The essential clinical work is to establish what episodes occurred and whether the documented history supports a specific classification. NICE guideline CG185, section 1.11 ISBD pediatric bipolar disorder task force
What a specialist asks
A comprehensive interview explores the teenager’s baseline temperament and behavior, dates and approximate lengths of possible episodes, mood alongside energy and activation, sleep patterns, concentration and school attendance, relationships, risky behavior, psychotic symptoms, suicidality, prior depression, family psychiatric history, and any periods of functioning well. The evaluator asks what teachers, caregivers, friends, and the teenager themselves observed, because accounts may differ. Medication exposure, stimulants, antidepressants, recreational substances, intoxication or withdrawal, endocrine illness, and neurological concerns require attention when indicated. National Institute of Mental Health (NIMH) ISBD pediatric bipolar disorder task force
A typical assessment also evaluates anxiety, ADHD, trauma, learning differences, autism-related needs, substance use, eating difficulties, family circumstances, bullying, and psychosocial adversity. These can influence symptoms, coexist with bipolar disorder, or suggest a different primary condition. The existence of another diagnosis never rules out bipolar disorder automatically, and the presence of manic-like symptoms never proves that every difficulty comes from bipolar disorder. Carlson, differential diagnosis review ISBD pediatric bipolar disorder task force
How can families help document episodes?
A family can prepare a dated account of sleep hours, observed activity level, mood changes, school attendance, major events, medications, substance exposure when known, and functional consequences. Descriptions such as “slept three hours for five nights and remained unusually energetic” help more than labels such as “acted bipolar.” When safe and appropriate, school observations can identify whether behavior changed across environments. Recording facts supports clinical assessment; it should never become surveillance, punishment, or a way to force a diagnosis. NICE guideline CG185, section 1.11 National Institute of Mental Health (NIMH)
Questionnaires and symptom scales sometimes help specialists organize interviews or track change, but diagnostic validity depends on age, setting, measure, and clinical context. NICE specifically advises against using questionnaires in primary care to identify bipolar disorder in young people. A high score or positive screening flag calls for assessment rather than automatic confirmation. NICE guideline CG185, section 1.11
When is more follow-up necessary?
The initial history can be incomplete. A teenager may recall depression vividly but underreport past hypomania; parents may remember behavioral changes without knowing the internal experience; psychotic symptoms may complicate the picture; and symptoms linked to medication or substance use may resolve or recur after exposure changes. A careful team may monitor prospectively, revisit alternative diagnoses, and update its judgment as reliable observations accumulate. Diagnostic revision is part of responsible longitudinal care. Carlson, differential diagnosis review ISBD pediatric bipolar disorder task force
What else can look like bipolar disorder in a teenager?
ADHD commonly involves longstanding distractibility, impulsivity, activity, and executive-function difficulties across settings. Mania is typically distinguished by a discrete, marked change from baseline with elevated or irritable mood and new symptoms such as a sharply reduced need for sleep and grandiosity. Both conditions can coexist; a clinician should document ADHD symptoms outside mood episodes before assuming comorbidity. ISBD pediatric bipolar disorder task force Carlson, differential diagnosis review
Disruptive mood dysregulation disorder involves chronic irritability and recurrent severe temper outbursts rather than distinct manic episodes. Major depressive disorder may explain significant depression without any convincing history of mania or hypomania. Anxiety conditions, trauma-related hyperarousal, personality development difficulties, and severe environmental stress can also produce restlessness, mood reactivity, disturbed sleep, or impulsive behavior. The longitudinal sequence and associated activation symptoms help distinguish these possibilities. Carlson, differential diagnosis review National Institute of Mental Health (NIMH)
Psychosis may appear during severe mood episodes. A specialist must determine whether psychotic symptoms occur only in the context of mood episodes or suggest a separate psychotic-spectrum condition, and assess the timing and safety needs. Substance effects, prescribed stimulants, antidepressant-associated activation, sleep deprivation, thyroid or neurological illness, and other medical explanations may alter the assessment. A medication-related switch is clinically important but still requires evaluation before it is treated as proof of lifelong bipolar disorder. ISBD pediatric bipolar disorder task force NICE guideline CG185, section 1.11
Causes and risk factors: what is known?
Bipolar disorder has a substantial familial and genetic component, but genetic vulnerability works through complex pathways and does not determine any individual teenager’s future. Family history matters during assessment because a close relative with bipolar disorder changes the background level of risk. Researchers continue to investigate neurodevelopment, circadian regulation, neural circuits, stress biology, and environmental exposures. No single confirmed cause or diagnostic biomarker explains all cases. ISBD pediatric bipolar disorder task force National Institute of Mental Health (NIMH)
Stressful events, irregular schedules, reduced sleep, substance exposure, and developmental transitions may precipitate or aggravate episodes in susceptible individuals. These factors also affect many teenagers who never develop bipolar disorder. It is therefore more accurate to describe them as potential contributors or clinical management targets than as a simple causal formula. Parents and adolescents are better served by a history-informed treatment plan than by attempts to identify one event or one person to blame. ISBD pediatric bipolar disorder task force National Institute of Mental Health (NIMH)
Treatment goals and how clinicians choose care
Treatment aims to reduce the current episode, restore safe sleep and functioning, prevent recurrence, address coexisting conditions, and preserve the young person’s education, relationships, physical health, and development. Selection depends on whether the present problem is mania, bipolar depression, or maintenance after an episode. Medication evidence is phase-specific; a treatment supported for acute mania is not thereby established for bipolar depression. The age-specific evidence base is smaller than the adult evidence base, and regulatory indications differ by country and product. CANMAT/ISBD 2023 evidence update NICE guideline CG185, section 1.11
Care is usually coordinated by a clinician trained in child and adolescent mental health. A multidisciplinary team may include a child and adolescent psychiatrist, therapist, primary-care clinician, family or caregivers, and school professionals as appropriate. Assessment of adolescent maturity, capacity to consent, caregiver involvement, safety, preferences, and confidentiality belongs in shared planning. NICE explicitly addresses these developmental and consent issues when choosing youth treatment. NICE guideline CG185, section 1.11
Treatment of acute mania
Severe mania can interfere with sleep, judgment, safety, and reality testing. Acute treatment may include a pediatric-appropriate antipsychotic, lithium, or another specialist-selected regimen, along with attention to hydration, sleep, substance exposure, supervision, and a safe care environment. Hospital evaluation may be necessary when there is psychosis, dangerous behavior, inability to care for basic needs, or an immediate threat to self or others. Families should seek urgent assessment rather than trying to manage dangerous mania through confrontation or sleep advice alone. NICE guideline CG185, section 1.11 CANMAT/ISBD 2023 evidence update
CANMAT/ISBD’s youth recommendations identify lithium and several antipsychotics among options for acute mania, while their adult drug hierarchies must not simply be copied into adolescent practice. In the pediatric TEAM trial, risperidone showed greater short-term response than lithium or divalproex in the studied children, alongside an adverse-effect burden that influences individual choice. The findings apply to the particular trial population and acute manic or mixed phase, not automatically to every teenager or to long-term treatment. CANMAT/ISBD 2023 evidence update Geller and colleagues, TEAM randomized trial
Treatment of bipolar depression
Bipolar depression may dominate the visible illness course and carry high functional and safety burdens. Psychological treatment, careful medication selection, and repeated suicide-risk assessment may all be appropriate depending on severity. NICE recommends a structured psychological intervention for young people with bipolar depression and a multidisciplinary review when response is limited; pharmacotherapy can be considered alongside psychological intervention for moderate to severe depression after individualized assessment. These NICE recommendations reflect a specific UK guideline context. NICE guideline CG185, section 1.11
For medication, evidence and approval depend on age and diagnosis. Lurasidone has randomized-trial evidence for bipolar I depression in ages 10 to 17 and U.S. labeling for that pediatric indication. A six-week trial demonstrated improvement on the measured depressive symptom outcome versus placebo; it did not establish that the same medicine treats acute mania or that every adolescent will respond. Selection still requires review of adverse effects, interacting medications, and ongoing monitoring. DelBello and colleagues, pediatric lurasidone trial DailyMed, lurasidone labeling
Antidepressants can be clinically complicated in bipolar illness because treatment-emergent mania, hypomania, agitation, or mixed symptoms may occur. An antidepressant is not a routine stand-alone treatment for bipolar I depression. If an adolescent is already taking one, a qualified prescriber should reassess its role and plan any changes; families should not abruptly stop prescribed treatment on the basis of an online article. CANMAT/ISBD 2023 evidence update NICE guideline CG185, section 1.11
Maintenance treatment and follow-up
After acute symptoms improve, the goals shift toward maintaining stability, monitoring recurrence, supporting school and social recovery, reducing medication burdens, and identifying emerging symptoms early. CANMAT/ISBD lists lithium, aripiprazole, and divalproex as first-line pediatric maintenance options in its guideline hierarchy, but selection rests on the individual’s episode history, previous response, risks, and monitoring feasibility. Long-term decisions need periodic review because adolescence brings rapid changes in growth, independence, relationships, and medical circumstances. CANMAT/ISBD 2023 evidence update NICE guideline CG185, section 1.11
Relapse prevention includes a written plan specifying early warning signs, whom to contact, how urgent symptoms will be evaluated, and how family and school can respond without stigma. Relevant triggers can include substantial sleep disruption, missed treatment, escalating substance use, and major stress. See Early Warning Signs of Mania and Bipolar Relapse for a dedicated guide to early warning signs.
Medication safety in teenagers
Psychiatric medicines require attention to benefit, potential adverse reactions, long-term metabolic and developmental effects, interactions, and the adolescent’s own preferences. The following sections describe questions that a treatment team considers; they are not prescribing instructions. U.S. drug approval is medicine-, indication-, and age-specific, while a clinician may sometimes consider an off-label option under specialist responsibility. Guidelines should be read in the context of the jurisdiction and date in which they were issued. NICE guideline CG185, section 1.11 CANMAT/ISBD 2023 evidence update
Lithium
Lithium is approved in the United States for acute manic or mixed episodes and maintenance treatment of bipolar I disorder from age seven for applicable products. It requires serum drug-level monitoring and attention to kidney function, thyroid function, electrolytes, dehydration, and interacting drugs. Toxicity may occur close to therapeutic blood concentrations. Vomiting, diarrhea, severe tremor, confusion, weakness, or impaired coordination in someone taking lithium warrant prompt medical assessment, especially if dehydration or a medication interaction is possible. Dose changes, initiation, and discontinuation are decisions for the prescribing team. DailyMed, lithium carbonate prescribing information
Antipsychotic medications
Some second-generation antipsychotics are used for pediatric mania and selected treatments for bipolar depression. Their benefits must be weighed against possible weight gain, lipid and glucose changes, sedation, restlessness or akathisia, movement-related adverse effects, and other drug-specific risks. Baseline and follow-up monitoring commonly includes weight or BMI, blood pressure, metabolic measurements, movement symptoms, and symptoms affecting school and daily life. The precise schedule depends on medicine, clinical risks, and local guideline. A medication approved for pediatric mania may not be approved for pediatric bipolar depression. NICE guideline CG185, section 1.11 CANMAT/ISBD 2023 evidence update
Lamotrigine
Lamotrigine appears in some clinical discussions of bipolar depression and maintenance, but evidence and licensing in pediatric bipolar disorder differ from adult indications. A key warning is the risk of serious skin reactions, particularly during initiation or dose escalation, and interactions that can increase risk. A new rash requires immediate contact with the prescriber and prompt clinical advice; concerning systemic symptoms may require emergency medical care. Adolescents and caregivers should follow the exact clinician-provided medication safety instructions rather than adjusting titration independently. NICE guideline CG185, section 1.11 CANMAT/ISBD 2023 evidence update
Valproate
Valproate can produce important adverse effects and has major reproductive and fetal risks, in addition to hepatic, pancreatic, weight, and metabolic concerns. NICE places strong restrictions on use in young people and incorporates UK regulator precautions affecting people of reproductive potential. These rules are jurisdiction-specific, but the underlying safety issue requires attention wherever treatment occurs. Any consideration of valproate for an adolescent calls for a documented specialist risk-benefit discussion, appropriate testing and monitoring, and individualized reproductive counseling with safeguards against coercion. NICE guideline CG185, section 1.11
Monitoring mood and physical health together
A teenager may need treatment monitoring at more than one level: current mood symptoms, suicidality, sleep, school functioning, medication tolerability, physical examination, relevant laboratory values, and the family’s ability to follow the care plan. Weight, appetite, concentration, restlessness, sexual or reproductive concerns, and side effects that interfere with sports or school are legitimate clinical topics. Regular review also helps reduce unnecessary medication continuation once an acute-phase plan has changed. NICE guideline CG185, section 1.11 CANMAT/ISBD 2023 evidence update
Psychotherapy and family-based care
Evidence-based psychological care can help adolescents and families understand episodes, manage stress, recognize recurrence, communicate more effectively, protect sleep routines, and rebuild functioning. Cognitive behavioral therapy, interpersonal approaches, psychoeducation, and family-focused interventions may be used as components of a comprehensive plan. For bipolar depression in young people, NICE specifies structured psychotherapy and a review of insufficient response rather than assuming that medication alone addresses educational and relational needs. NICE guideline CG185, section 1.11
Family-focused treatment has been studied in adolescents with bipolar I and bipolar II disorders. A two-year randomized trial did not find a clear advantage over a shorter psychoeducational comparison for time to recovery or recurrence on its principal outcomes, although symptomatic benefits may vary by measure. Trials of family-focused treatment in young people at familial risk concern a related but different population and cannot be taken as proof of prevention for every child of an affected parent. The evidence supports using psychosocial interventions thoughtfully while avoiding promises of universal relapse prevention. Miklowitz and colleagues, adolescent family-focused trial Miklowitz and colleagues, high-risk youth trial
A family session may focus on how to discuss warning signs without accusation, agree on practical steps during sleep disruption, navigate medication concerns, reduce blame, and plan responses when judgment deteriorates. Therapists should also offer the teen opportunities to speak privately. The goal is a collaborative safety and recovery system that respects growing independence, including when the adolescent and caregivers disagree. NICE guideline CG185, section 1.11
School, friends, and everyday life
Mood episodes can disrupt attendance, homework, examinations, peer relationships, athletics, and ordinary routines. Return to school after a major episode may require a gradual plan, realistic workload, predictable sleep and medication schedules, and agreed communication between caregivers, the adolescent, and school personnel. Accommodations should be based on functional needs rather than an assumption that every teenager with bipolar disorder has the same difficulties. National Institute of Mental Health (NIMH) NICE guideline CG185, section 1.11
Families and schools can focus on observable needs: opportunities to make up assignments after treatment, temporary workload adjustments during recovery, minimizing punitive interpretations of illness-related behavior, and clear pathways for urgent contact. The teen should participate as much as their developmental level and safety allow, including in decisions about what personal health information is shared. A school plan is a support arrangement, not a substitute for specialist clinical care. NICE guideline CG185, section 1.11
Peer support, exercise, meaningful activities, and social connection may help overall well-being. They do not replace acute treatment of mania or severe bipolar depression. Alcohol and recreational drugs can complicate diagnosis, interact with treatment, and affect judgment. Families benefit from factual, calm conversations and access to appropriate substance-use assessment when needed. National Institute of Mental Health (NIMH) NICE guideline CG185, section 1.11
Sleep, routines, and early warning signs
Consistent sleep timing and a manageable daily rhythm can support stability. The goal is realistic protection of sleep, not rigid policing. A plan can specify who to call when a teen experiences several nights of very little sleep with unusual energy, sudden high-risk plans, or a rapid and sustained change in functioning. A teenager should not be punished for reporting a concerning change; early disclosure provides more options for preventive clinical assessment. National Institute of Mental Health (NIMH) Early Warning Signs of Mania and Bipolar Relapse
Mood tracking can be useful when it records simple facts and leads to collaborative discussion. Constant checking, surveillance through devices, or interpreting every emotion as a symptom can damage trust. A supportive plan leaves room for privacy, ordinary adolescent experimentation, social life, and individual development while highlighting the specific episode patterns that have previously preceded relapse. NICE guideline CG185, section 1.11
Suicide risk, severe mania, and when to get urgent help
Bipolar depression and mixed or manic episodes can involve elevated suicide risk, impaired judgment, psychosis, or behavior that endangers the adolescent. Immediate warning signs include expressed intent to die, a suicide plan or preparation, severe confusion, threats or acts of violence, hallucinations or delusions with unsafe behavior, inability to care for basic needs, and pronounced activation with little sleep and rapidly worsening judgment. Urgent care is appropriate even while the exact diagnosis is still being assessed. National Institute of Mental Health (NIMH) NICE guideline CG185, section 1.11
If there is an immediate danger, call the local emergency number or go to the nearest emergency department. In the United States, call or text 988 for crisis support; call 911 for a life-threatening emergency. Stay with the teen when safe, reduce access to firearms, medications, or other lethal means, and tell the responding clinician about any recent substances or prescription changes. Do not leave a suicidal young person alone while attempting to resolve the situation only through an online chat or family argument. National Institute of Mental Health (NIMH)
For serious but non-immediate concerns, contact the treating mental-health service promptly for reassessment. Parents and other trusted adults should take statements about suicide seriously and ask directly about current thoughts of self-harm. A safety plan should identify accessible people, specific steps, crisis services, and what to do if symptoms intensify. Hospitalization is sometimes necessary to address a short-term threat; it is a treatment setting decision, not a verdict on the teenager’s future. NICE guideline CG185, section 1.11 National Institute of Mental Health (NIMH)
Consent, confidentiality, and the teenager's role in treatment
Adolescent mental-health care works best when the young person receives a developmentally appropriate explanation of the diagnosis under consideration, the expected benefits and risks of proposed treatments, alternatives, monitoring, and what to do if side effects or worsening symptoms occur. Capacity to consent and the legal role of parents or guardians vary with the teenager’s age, clinical state, and jurisdiction. Clinicians should explain what remains confidential and what safety-related information must be shared. NICE guideline CG185, section 1.11
Parents can contribute valuable longitudinal information and day-to-day support without eliminating the teenager’s voice. Questions about relationships, sexual health, substance use, identity, and suicidal thoughts may require confidential time with a clinician. In emergencies, protection of the young person’s immediate safety governs the necessary response. Shared decision-making should include consideration of how treatments affect study, sleep, self-image, growth, family relationships, and the teenager’s longer-term goals. NICE guideline CG185, section 1.11
Prognosis: can a teenager with bipolar disorder have a stable life?
Many young people improve substantially with appropriate treatment and follow-up, but bipolar disorder may recur and can affect functioning between major episodes. Prognosis varies with episode pattern, access to timely treatment, coexisting conditions, medication tolerability, sleep stability, family circumstances, and individual goals. A period without symptoms is meaningful; it should be evaluated alongside the longer-term plan rather than taken as automatic evidence that ongoing care is unnecessary. National Institute of Mental Health (NIMH) ISBD pediatric bipolar disorder task force
Recovery includes more than symptom scores. It may mean returning to school, rebuilding friendships, learning to recognize warning signs, participating in care decisions, and developing ordinary independence. An effective follow-up plan can adapt as the adolescent moves into adult services. NICE specifically includes transition planning in its care recommendations. NICE guideline CG185, section 1.11
What parents and caregivers can do now
Begin with accurate observations and a calm conversation about changes in sleep, energy, mood, and functioning. Ask what the young person has noticed and what kind of support would help. If a possible manic or hypomanic syndrome is present, arrange assessment with a youth mental-health clinician and describe the episode history rather than requesting a diagnosis by name. Seek urgent help for immediate safety concerns. National Institute of Mental Health (NIMH) NICE guideline CG185, section 1.11
Before an appointment, collect a concise chronology of symptoms, medications, relevant family history, attendance or functional changes, and any prior emergency evaluations. During treatment, clarify whom to contact for new activation, depressed mood, medication reactions, or missed follow-up. Discuss side effects openly and avoid unilateral stopping or dose changes. Caregivers also need opportunities for education and support; family stress and exhaustion can interfere with the best possible plan. NICE guideline CG185, section 1.11
Frequently asked questions
Can puberty or hormones cause bipolar disorder?
Puberty brings hormonal, sleep, and social changes that can affect emotion and behavior. Bipolar disorder is associated with complex developmental and familial vulnerability rather than a single established hormonal cause. Puberty alone does not diagnose or explain a manic episode. Clinicians assess the symptom pattern and medical context, including whether another condition may account for changes. National Institute of Mental Health (NIMH) ISBD pediatric bipolar disorder task force
At what age can bipolar disorder be diagnosed?
Bipolar disorder can occur before adulthood, although diagnostic uncertainty and developmental differences are especially important in younger patients. The age at diagnosis is less informative than whether a specialist can establish a convincing clinical episode history and distinguish it from other conditions. Available youth treatment indications also vary by medication and age. National Institute of Mental Health (NIMH) CANMAT/ISBD 2023 evidence update
How long does a bipolar episode last in teenagers?
Conventional diagnostic thresholds include at least seven days for mania unless hospitalization is required, four days for hypomania, and two weeks for a major depressive episode. Real histories can include longer, shorter, overlapping, or incompletely recalled symptom periods. Duration is interpreted with severity, associated activation, impairment, and follow-up, rather than serving as a self-test. CANMAT/ISBD 2023 evidence update ISBD pediatric bipolar disorder task force
Does a teenager who is angry or impulsive have bipolar disorder?
Anger and impulsivity occur in many settings, including ordinary development, ADHD, trauma-related problems, chronic irritability conditions, sleep loss, and substance effects. A bipolar assessment looks for distinct episodes with changes in mood and activation that clearly exceed baseline. Persistent anger without episodes demands care based on its actual causes and consequences. Carlson, differential diagnosis review
Can bipolar disorder and ADHD occur together?
Yes. A clinician should still distinguish longstanding baseline ADHD symptoms from new episode-linked distractibility, reduced sleep need, grandiosity, or heightened activity. Both disorders may need treatment, and the safety and sequencing of medication decisions require individual specialist assessment. ISBD pediatric bipolar disorder task force
Can a teenager have bipolar disorder without obvious mania?
Someone with bipolar II disorder experiences hypomania rather than mania, and hypomania may be overlooked by families or the teenager. Bipolar I requires at least one manic episode, and bipolar II requires hypomania plus major depression. A history consisting only of depression and a family history of bipolar disorder does not establish the diagnosis. CANMAT/ISBD 2023 evidence update NICE guideline CG185, section 1.11
Will medication change my teenager’s personality?
An effective medication should reduce harmful episodes while preserving the teenager’s ability to learn, relate, and pursue meaningful activities. Some treatments can cause sedation, restlessness, cognitive complaints, weight changes, or other effects that require review. The family and adolescent should discuss these openly with the prescriber; treatment can be reassessed without abrupt unsupervised changes. NICE guideline CG185, section 1.11 DailyMed, lithium carbonate prescribing information
What if my teenager refuses treatment?
The next step depends on their capacity, level of risk, reasons for refusal, and local consent law. Listening to adverse-effect concerns, arranging private time with a clinician, offering age-appropriate explanations, and including the adolescent in options may help. Severe mania, psychosis, or imminent self-harm risk may require urgent safety assessment even if routine engagement has been difficult. NICE guideline CG185, section 1.11
Can a teen with bipolar disorder attend school and have relationships?
Yes. Functional recovery is a central treatment goal. Some young people need temporary educational accommodations or support after an episode; others maintain attendance with a stable care plan. The needed supports should be adapted to the person’s symptoms, preferences, and school environment rather than imposing a universal limitation. National Institute of Mental Health (NIMH) NICE guideline CG185, section 1.11
Is an online bipolar test enough to know?
No. Questionnaires can collect symptom reports but cannot establish the clinical significance, episode timing, differential diagnosis, or medical explanations. NICE advises against using primary-care questionnaires to identify youth bipolar disorder, and NIMH states that diagnosis requires careful clinical evaluation. NICE guideline CG185, section 1.11 National Institute of Mental Health (NIMH)
Related Articles
References
Carlson, G. A. (2012). Differential diagnosis of bipolar disorder in children and adolescents. World Psychiatry, 11(3), 146–152. Carlson, differential diagnosis review
DelBello, M. P., et al. (2017). Efficacy and safety of lurasidone in children and adolescents with bipolar I depression: A double-blind, placebo-controlled study. Journal of the American Academy of Child & Adolescent Psychiatry, 56(12), 1015–1025. DelBello and colleagues, pediatric lurasidone trial
Geller, B., et al. (2012). A randomized controlled trial of risperidone, lithium, or divalproex sodium for initial treatment of bipolar I disorder, manic or mixed phase, in children and adolescents. Archives of General Psychiatry, 69(5), 515–528. Geller and colleagues, TEAM randomized trial
Goldstein, B. I., et al. (2017). The International Society for Bipolar Disorders Task Force report on pediatric bipolar disorder: Knowledge to date and directions for future research. Bipolar Disorders. ISBD pediatric bipolar disorder task force
Keramatian, K., Chithra, N. K., & Yatham, L. N. (2023). The CANMAT and ISBD Guidelines for the Treatment of Bipolar Disorder: Summary and a 2023 Update of Evidence. Focus, 21(4), 344–353. CANMAT/ISBD 2023 evidence update
Miklowitz, D. J., et al. (2014). Pharmacotherapy and family-focused treatment for adolescents with bipolar I and II disorders: A 2-year randomized trial. American Journal of Psychiatry, 171(6), 658–667. Miklowitz and colleagues, adolescent family-focused trial
Miklowitz, D. J., et al. (2020). Effects of family-focused therapy vs enhanced usual care for symptomatic youths at high risk for bipolar disorder: A randomized clinical trial. JAMA Psychiatry, 77(5), 455–463. Miklowitz and colleagues, high-risk youth trial
National Institute for Health and Care Excellence. (2014; guidance updated 2025). Bipolar disorder: Assessment and management (CG185), recommendations including section 1.11. NICE guideline CG185, section 1.11
National Institute of Mental Health. (n.d.). Bipolar disorder in children and teens. National Institute of Mental Health (NIMH)
National Institute of Mental Health. (n.d.). Bipolar disorder in teens and young adults: Know the signs. NIMH: Signs for teens and young adults
National Library of Medicine. (n.d.). Lithium carbonate: U.S. prescribing information (DailyMed). DailyMed, lithium carbonate prescribing information
National Library of Medicine. (2026). Lurasidone hydrochloride: U.S. prescribing information (DailyMed). DailyMed, lurasidone labeling
U.S. Department of Veterans Affairs & Department of Defense. (2023). Management of bipolar disorder: Clinical practice guideline. General adult-service context; pediatric recommendations above rely on pediatric-specific sources. VA/DoD bipolar disorder guideline (2023)